Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
empagliflozin (jardiance) (1 trial)
honey (1 trial)
COVID-19 convalescent plasma (1 trial)
remdesivir (1 trial)
tocilizumab (actemra) (1 trial)
methylprednisolone (medrol) (1 trial)
Coronavirus Infections (Phase 1)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Severe Acute Respiratory Syndrome (Phase 1)
Trials (6 total)
Trial APIs (6 total)